WGSWW
GeneDx Holdings Corp.NASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
2.19
52W High
$0.19
52W Low
$0.00
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-4.92%
Forward P/E
—
PEG Ratio
—
About GeneDx Holdings Corp.
GeneDx Holdings Corp. (Ticker: WGSWW) is a leader in the genomics sector, specializing in genomic testing and precision medicine aimed at diagnosing rare and undiagnosed genetic conditions. Utilizing cutting-edge sequencing technologies and an extensive database of genetic knowledge, GeneDx equips healthcare providers with essential diagnostic tools that inform treatment strategies. The company’s diverse portfolio of genetic testing services and its strategic partnerships within the healthcare ecosystem position it favorably in an increasingly competitive market, underscoring its commitment to advancing personalized medicine and enhancing patient outcomes through innovative solutions in genetic healthcare.
Fundamentals
| Revenue (TTM) | $427.54M |
| Gross Profit (TTM) | $298.18M |
| EBITDA | $12.65M |
| Operating Margin | -10.60% |
| Return on Equity | -7.60% |
| Return on Assets | -1.55% |
| Revenue/Share (TTM) | $14.93 |
| Book Value | $10.54 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 26.50% |
| Shares Outstanding | 0 |
| Float | $20.85M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/20/2026